Challenge Cancer: Cycle London to Brighton 2015
Get your place
Got a place already?
Request your sponsorship pack and join our team.
Ride 100km from London to Brighton and help beat cancer sooner.
Cycle through the night and take to the road by moonlight in this brand new challenge. The ride will begin at Smithfield's Market, Central London and will take you 100km to the scenic coast of Brighton. Whether you're a novice or a keen cyclist, this event is for you and we're looking forward to seeing you there.
In 2015 there are more ways than ever to be part of the London 2 Brighton Cycle, sign up to:
Day Ride (100km) - The day ride will start on the morning of the 27th between 7-9am and is ideal for those riders who want to see the scenic route in glorious day light.
Night Ride (100km) - The night ride will begin on the evening of the 26th and is best suited to those riders who come alive after dark.
There & Back (200km) - Think you are tough enough for the ultimate 200km cycle? The There & Back ride will start on Saturday night and will see you making your way to Brighton over night, before turning around and coming back to London. This is not one for the feint hearted.
Register as an individual or bring some friends along and join as a team.
N.B. You'll need to have raised 50% of your sponsorship target 6 weeks before the event to confirm your place. But don't worry, we've got loads of fundraising tips and support to help you achieve this.
For more information on this challenge visit the official event page.
Sign up before the 24th December 2014 and receive 50% off your registration fee with the 'early bird offer'.
Race Day Information
We'll get you to the finish line. We've got training and fundraising advice, cheering packs for your friends and family, and a dedicated team ready to answer any last minute questions.
Any questions? Contact the Sports Team on 0300 123 5461 or email firstname.lastname@example.org.
Did you know
Cancer Research UK identified faulty genes that drive cancer cells to grow – such as BRAF in skin cancer and EGFR in lung and other cancers - paving the way for important new targeted treatments.